Skip to main content
VCbacked
Log inGet Started

Quanta Therapeutics

San Francisco, United States

Quanta is a biotechnology company uncovering novel cancer therapeutic candidates using allosteric modulation to target driver oncogenes.

$50.7M raised
May 2023
Series D
BiotechnologyHealth CareMedical DeviceTherapeutics

Top Investors

AbbVieLongitude CapitalVida VenturesSofinnova InvestmentsAvidity Partners

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Quanta Therapeutics

How much funding has Quanta Therapeutics raised?
Quanta Therapeutics has raised $50.7M in total funding. The most recent round was Series D. The last funding was announced in May 2023.
Who are Quanta Therapeutics's investors?
Quanta Therapeutics's investors include AbbVie, Longitude Capital, Vida Ventures, Sofinnova Investments, Avidity Partners.
Where is Quanta Therapeutics headquartered?
Quanta Therapeutics is headquartered in San Francisco, United States.
What does Quanta Therapeutics do?
Quanta is a biotechnology company uncovering novel cancer therapeutic candidates using allosteric modulation to target driver oncogenes.
What stage is Quanta Therapeutics at?
Quanta Therapeutics is at the Series D stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Quanta Therapeutics — Funding & Investors." VCBacked, May 22, 2023, https://www.vcbacked.co/company/quanta-therapeutics. Accessed July 3, 2026.
APA
VCBacked. (2023). Quanta Therapeutics — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/quanta-therapeutics
Wikipedia (cite web)
{{cite web |title=Quanta Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/quanta-therapeutics |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Rapport Therapeutics
Boston$250.0M
Allterum Therapeutics
Houston$1.0M
AlpalifeBio
Woburn$9.8M
Renaissance BioScience
Vancouver$599K
Epsilogen
London$16.3M
Advanced Microbiome Interventions
Amsterdam$300K